# Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis

> **NCT02858817** · PHASE1 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 30 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** atovaquone/proguanil 250mg/100mg (A/P)
- **BIOLOGICAL:** PfSPZ Challenge (NF54)
- **OTHER:** NaCl 0,9%

## Key facts

- **NCT ID:** NCT02858817
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-28
- **Primary completion:** 2017-11-16
- **Final completion:** 2017-11-16
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02858817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02858817, "Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02858817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*